BiotechTubeBiotechTube
Home/NewAmsterdam Pharma Company/Patrick J. McEnany
PJ

Patrick J. McEnany

Chairman of the Board of Directors

NewAmsterdam Pharma Company

Roles

Chairman of the Board of DirectorsatNewAmsterdam Pharma Company
Co-Founder and ChairmanatCatalyst Pharmaceuticals
DirectoratCassava Sciences
Board MemberatRafael Holdings

Therapeutic Areas

CardiovascularMetabolic DiseasesDyslipidemia

NewAmsterdam Pharma Company Pipeline

DrugIndicationPhase
ObicetrapibHeterozygous Familial Hypercholesterolemia (HeFH) and/or established Atherosclerotic Cardiovascular Disease (ASCVD)Phase 3
NA-0111Undisclosed metabolic indicationPreclinical

Leadership Team at NewAmsterdam Pharma Company

JK
John Kastelein
Chief Scientific Officer and Founder
MD
Michael Davidson
Chief Executive Officer
ES
Evan Stein
Chief Medical Officer and Founder
BG
Brenton G. Ahrens
Chief Financial Officer
MD
Menno de Vries
Chief Operating Officer
CK
Chris K. Lee
General Counsel
AV
Annemieke van Vuuren
Chief Human Resources Officer
JE
James E. Flynn
Director
AE
Andrew ElBardissi
Director
LA
Lishan Aklog
Director
View full NewAmsterdam Pharma Company profile